Kisunla (donanemab-azbt) is a drug used to treat early stages of Alzheimer’s disease:
How it works:
Kisunla is an antibody that binds to amyloid plaques in the brain, which are a key part of Alzheimer’s disease. The body can then clear the plaques, which can slow the progression of the disease.